Navigation Links
Major step toward an Alzheimer's vaccine
Date:1/15/2013

This press release is available in French.

Quebec City, January 15, 2013A team of researchers from Universit Laval, CHU de Qubec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This major breakthrough, details of which are presented today in an early online edition of the Proceedings of the National Academy of Sciences (PNAS), opens the door to the development of a treatment for Alzheimer's disease and a vaccine to prevent the illness.

One of the main characteristics of Alzheimer's disease is the production in the brain of a toxic molecule known as amyloid beta. Microglial cells, the nervous system's defenders, are unable to eliminate this substance, which forms deposits called senile plaques.

The team led by Dr. Serge Rivest, professor at Universit Laval's Faculty of Medicine and researcher at the CHU de Qubec research center, identified a molecule that stimulates the activity of the brain's immune cells. The molecule, known as MPL (monophosphoryl lipid A), has been used extensively as a vaccine adjuvant by GSK for many years, and its safety is well established.

In mice with Alzheimer's symptoms, weekly injections of MPL over a twelve-week period eliminated up to 80% of senile plaques. In addition, tests measuring the mice's ability to learn new tasks showed significant improvement in cognitive function over the same period.

The researchers see two potential uses for MPL. It could be administered by intramuscular injection to people with Alzheimer's disease to slow the progression of the illness. It could also be incorporated into a vaccine designed to stimulate the production of antibodies against amyloid beta. "The vaccine could be given to people who already have the disease to stimulate their natural immunity," said Serge Rivest. "It could also be administered as a preventive measure to people with risk factors for Alzheimer's disease."

"When our team started working on Alzheimer's disease a decade ago, our goal was to develop better treatment for Alzheimer's patients," explained Professor Rivest. "With the discovery announced today, I think we're close to our objective."


'/>"/>
Contact: Jean-Franois Hupp
jean-francois.huppe@dc.ulaval.ca
418-656-7785
Universit Laval
Source:Eurekalert

Related medicine news :

1. Scientists identify major source of cells defense against oxidative stress
2. Majority of Californias Medi-Cal caregivers live in or near poverty
3. Study reveals major funding shortfall and high death rates for emergency laparotomy
4. Groundbreaking Nigeria summit results in major commitment to reduce child deaths
5. Majority of states fail to address youth exposure to alcohol marketing
6. Researchers determine vitamin D blood level for reducing major medical risks in older adults
7. Dengue Fever a Major Cost Burden in Puerto Rico
8. Living Near Major Roads May Shorten Heart Attack Survival
9. Bias found in mental health drug research presented at major psychiatric meeting
10. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
11. Infant Formula Can Be a Major Source of BPA: Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... “Mysteries Revealed On Speaking In ... mysterious phenomenon is available to all Christians. “Mysteries Revealed On Speaking In Tongues” is ... Beautiful Creation,” a Christian-based talk show located in Michigan. , “We need to ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... breast implants, a new scientific article suggests that autologous fat grafting—taking ... for achieving larger breasts naturally, without breast implants. , Cosmetic Surgeon and ...
(Date:1/24/2017)... IL (PRWEB) , ... January 23, 2017 , ... ... is partnering with Plug and Play, the world’s largest start-up platform headquartered in ... companies a year. , OSF Ventures recently signed a three-year agreement to ...
(Date:1/24/2017)... Texas (PRWEB) , ... January 23, 2017 , ... ... its presence in Texas with the acquisitions of two personal care service companies: ... in Texas City, Texas, effective January 1, 2017. , Well regarded in their ...
(Date:1/24/2017)... ... January 23, 2017 , ... Somnoware, ... plugin that allows sleep centers to automatically connect and initialize all their devices ... client browser plugin is quickly installed on first use and then monitors device ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Direct-to-consumer digital marketing strategy drives 85% ... in consumable sales, quarter-over-quarter ... ), a leader in digital health and mobile health ... Monitoring System, an all-in-one diabetes meter, today announced continued ... smart diabetes management solution. In just ...
(Date:1/23/2017)... 2017 Research and Markets has announced the addition ... Product - Forecast to 2025" report to their offering. ... Report Highlights: ... to identify the investment opportunities Market forecasts till 2025, ... market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... NEW YORK , January 23, 2017 ... Biotech equities to see how they have fared at the close: ... BPMX), OvaScience Inc. (NASDAQ: OVAS ), and Regeneron Pharmaceuticals ... the NASDAQ, Biotechnology shares were relative laggards on Friday, January 20 ... can access our complimentary research reports on these stocks now at: ...
Breaking Medicine Technology: